Refacto



Indications and Reactions:

Role Indications Reactions
Primary
Factor Viii Deficiency 64.9%
Haemophilia 7.6%
Prophylaxis 4.9%
Haemorrhage 2.7%
Pain 2.7%
Haemorrhage Prophylaxis 2.0%
Knee Arthroplasty 2.0%
Viral Infection 2.0%
Constipation 1.3%
Hypertension 1.1%
Off Label Use 1.1%
Post Procedural Haemorrhage 1.1%
Anti Factor Viii Antibody Positive 0.9%
Central Venous Catheterisation 0.9%
Cerebral Haemorrhage 0.9%
Migraine 0.9%
Surgery 0.9%
Candidiasis 0.7%
Convulsion 0.7%
Traumatic Haemorrhage 0.7%
Factor Viii Inhibition 39.7%
Haemarthrosis 10.3%
Haemorrhage 7.8%
Drug Ineffective 6.6%
Muscle Haemorrhage 4.9%
Anti Factor Viii Antibody Positive 4.6%
Pain In Extremity 4.3%
Haematoma 3.4%
Therapy Non-responder 3.2%
No Therapeutic Response 2.3%
Spontaneous Haematoma 2.3%
Infection 1.7%
Drug Specific Antibody Present 1.1%
Ecchymosis 1.1%
Free Haemoglobin Present 1.1%
Hypersensitivity 1.1%
Incorrect Product Storage 1.1%
Post Procedural Haemorrhage 1.1%
Weight Increased 1.1%
Central Venous Catheter Removal 0.9%
Secondary
Factor Viii Deficiency 60.3%
Haemorrhage Prophylaxis 6.1%
Pain 4.8%
Prophylaxis 4.2%
Anti Factor Viii Antibody Positive 3.2%
Bronchitis Chronic 2.9%
Constipation 2.3%
Haemophilia 1.9%
Central Venous Catheterisation 1.4%
Cerebral Haemorrhage 1.4%
Hypertension 1.4%
Knee Arthroplasty 1.4%
Migraine 1.4%
Haemorrhage 1.3%
Candidiasis 1.1%
Convulsion 1.1%
Hiv Infection 1.0%
Viral Infection 1.0%
Arthralgia 0.8%
Arthritis 0.8%
Factor Viii Inhibition 36.0%
Pain In Extremity 10.0%
Free Haemoglobin Present 6.6%
Haemorrhage 6.2%
Drug Ineffective 5.2%
Haemarthrosis 4.5%
Spontaneous Haematoma 4.5%
Haematoma 4.3%
Anti Factor Viii Antibody Positive 3.6%
Ecchymosis 3.1%
Post Procedural Haemorrhage 3.1%
Drug Specific Antibody Present 2.8%
Traumatic Brain Injury 2.1%
Infection 1.4%
Muscle Haemorrhage 1.4%
No Therapeutic Response 1.2%
Synovitis 1.2%
Hypersensitivity 0.9%
Oesophageal Varices Haemorrhage 0.9%
Pleurisy 0.9%
Concomitant
Hepatitis C 35.3%
Chronic Hepatitis C 17.6%
Haemophilia 17.6%
Hypertension 17.6%
Prophylaxis 11.8%
Photosensitivity Reaction 60.0%
Haemarthrosis 40.0%